Frédéric Lévy

3.8k total citations
61 papers, 3.1k citations indexed

About

Frédéric Lévy is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Frédéric Lévy has authored 61 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 35 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Frédéric Lévy's work include Immunotherapy and Immune Responses (33 papers), T-cell and B-cell Immunology (18 papers) and vaccines and immunoinformatics approaches (17 papers). Frédéric Lévy is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), T-cell and B-cell Immunology (18 papers) and vaccines and immunoinformatics approaches (17 papers). Frédéric Lévy collaborates with scholars based in Switzerland, United States and Belgium. Frédéric Lévy's co-authors include Jean‐Charles Cerottini, Alexander Varshavsky, Pedro Romero, Philippe Guillaume, R. Jürgen Dohmen, Laurence Chapatte, Michel Ghislain, Danila Valmori, Benoı̂t J. Van den Eynde and Sandra Morel and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Frédéric Lévy

61 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Lévy Switzerland 30 1.9k 1.6k 957 380 347 61 3.1k
Kunio Tsujimura Japan 31 1.4k 0.7× 1.1k 0.7× 481 0.5× 180 0.5× 488 1.4× 84 2.7k
Oxana A. Malakhova United States 13 1.4k 0.7× 1.4k 0.9× 736 0.8× 195 0.5× 113 0.3× 13 2.5k
Joëlle Wiels France 32 1.1k 0.6× 1.6k 1.0× 687 0.7× 321 0.8× 219 0.6× 91 3.3k
Hans-Georg Rammensee Germany 29 2.7k 1.4× 1.9k 1.2× 813 0.8× 241 0.6× 330 1.0× 50 4.0k
Loredana Saveanu France 28 1.7k 0.9× 1.1k 0.7× 659 0.7× 170 0.4× 180 0.5× 47 2.7k
Rachel M. Gerstein United States 32 2.3k 1.2× 1.5k 0.9× 528 0.6× 248 0.7× 115 0.3× 61 4.0k
Robert Jan Lebbink Netherlands 29 860 0.4× 1.7k 1.0× 483 0.5× 348 0.9× 234 0.7× 67 3.1k
Brian Zarnegar United States 26 2.2k 1.1× 2.4k 1.5× 705 0.7× 166 0.4× 270 0.8× 29 4.3k
Berit Jungnickel Germany 23 766 0.4× 1.7k 1.0× 556 0.6× 578 1.5× 540 1.6× 48 2.9k
Marlieke L.M. Jongsma Netherlands 16 1.3k 0.7× 994 0.6× 495 0.5× 156 0.4× 333 1.0× 26 2.4k

Countries citing papers authored by Frédéric Lévy

Since Specialization
Citations

This map shows the geographic impact of Frédéric Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Lévy more than expected).

Fields of papers citing papers by Frédéric Lévy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Lévy. The network helps show where Frédéric Lévy may publish in the future.

Co-authorship network of co-authors of Frédéric Lévy

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Lévy. A scholar is included among the top collaborators of Frédéric Lévy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Lévy. Frédéric Lévy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Postupalenko, Viktoriia, Léo Marx, David Viertl, et al.. (2023). Site-selective template-directed synthesis of antibody Fc conjugates with concomitant ligand release. Chemical Science. 15(4). 1324–1337. 10 indexed citations
2.
Postupalenko, Viktoriia, Léo Marx, David Viertl, et al.. (2022). Template directed synthesis of antibody Fc conjugates with concomitant ligand release. Chemical Science. 13(14). 3965–3976. 11 indexed citations
3.
Cervantes‐Barragán, Luisa, Roland Züst, Reinhard Maier, et al.. (2010). Dendritic Cell-Specific Antigen Delivery by Coronavirus Vaccine Vectors Induces Long-Lasting Protective Antiviral and Antitumor Immunity. mBio. 1(4). 42 indexed citations
4.
Baumann, Claudia, Cecilia Lindholm, Donata Rimoldi, & Frédéric Lévy. (2010). The E3 ubiquitin ligase Itch regulates sorting nexin 9 through an unconventional substrate recognition domain. FEBS Journal. 277(13). 2803–2814. 18 indexed citations
5.
Chalifour, Anick, Léonardo Scarpellino, Jonathan Back, et al.. (2009). A Role for cis Interaction between the Inhibitory Ly49A Receptor and MHC Class I for Natural Killer Cell Education. Immunity. 30(3). 337–347. 99 indexed citations
6.
Scarpellino, Léonardo, Franziska M. Oeschger, Philippe Guillaume, et al.. (2007). Interactions of Ly49 Family Receptors with MHC Class I Ligands in trans and cis. The Journal of Immunology. 178(3). 1277–1284. 70 indexed citations
7.
Derré, Laurent, Cédric Touvrey, Estelle Devêvre, et al.. (2007). A Novel Population of Human Melanoma-Specific CD8 T Cells Recognizes Melan-AMART-1 Immunodominant Nonapeptide but Not the Corresponding Decapeptide. The Journal of Immunology. 179(11). 7635–7645. 19 indexed citations
8.
Walton, Senta M., Marco Gerlinger, Olga de la Rosa, et al.. (2006). Spontaneous CD8 T Cell Responses against the Melanocyte Differentiation Antigen RAB38/NY-MEL-1 in Melanoma Patients. The Journal of Immunology. 177(11). 8212–8218. 21 indexed citations
9.
Colombetti, Sara, Petra Baumgärtner, Laurence Chapatte, et al.. (2006). Impact of Orthologous Melan-A Peptide Immunizations on the Anti-Self Melan-A/HLA-A2 T Cell Cross-Reactivity. The Journal of Immunology. 176(11). 6560–6567. 6 indexed citations
10.
Esslinger, Christoph, Laurence Chapatte, Daniela Finke, et al.. (2003). In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8+ T cell responses. Journal of Clinical Investigation. 111(11). 1673–1681. 120 indexed citations
11.
Lévy, Frédéric, Lena Burri, Sandra Morel, et al.. (2002). The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases. The Journal of Immunology. 169(8). 4161–4171. 67 indexed citations
12.
Ayyoub, Maha, Stefan Stevanović, Uğur Şahin, et al.. (2002). Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma. The Journal of Immunology. 168(4). 1717–1722. 100 indexed citations
13.
Miconnet, Isabelle, et al.. (2002). Testing mouse mammary tumor virus superantigen as adjuvant in cytotoxic T‐lymphocyte responses against a melanoma tumor antigen. International Journal of Cancer. 99(2). 201–206. 3 indexed citations
14.
Ayyoub, Maha, Marco Migliaccio, Philippe Guillaume, et al.. (2001). Lack of tumor recognition by hTERT peptide 540-548-specific CD8+ T cells from melanoma patients reveals inefficient antigen processing. European Journal of Immunology. 31(9). 2642–2651. 71 indexed citations
15.
Rimoldi, Donata, Katja Muehlethaler, Suzanne Salvi, et al.. (2001). Subcellular Localization of the Melanoma-associated Protein Melan-AMART-1 Influences the Processing of Its HLA-A2-restricted Epitope. Journal of Biological Chemistry. 276(46). 43189–43196. 23 indexed citations
16.
Valmori, Danila, Frédéric Lévy, Isabelle Miconnet, et al.. (2000). Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue. The Journal of Immunology. 164(2). 1125–1131. 64 indexed citations
17.
Kwon, Yong Tae, Frédéric Lévy, & Alexander Varshavsky. (1999). Bivalent Inhibitor of the N-end Rule Pathway. Journal of Biological Chemistry. 274(25). 18135–18139. 32 indexed citations
18.
Lévy, Frédéric, Jennifer Johnston, & A Varshavsky. (1999). Analysis of a conditional degradation signal in yeast and mammalian cells. European Journal of Biochemistry. 259(1-2). 244–252. 41 indexed citations
19.
Lévy, Frédéric, A. J. Bircher, & Jan‐Olaf Gebbers. (1996). Adult onset of cow's milk protein allergy with small‐intestinal mucosal IgE mast cells. Allergy. 51(6). 417–420. 7 indexed citations
20.
Kvist, Sune & Frédéric Lévy. (1993). Early events in the assembly of MHC class I antigens. Seminars in Immunology. 5(2). 105–116. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kunio Tsujimura Breakdown of academic impact, for papers by Oxana A. Malakhova Breakdown of academic impact, for papers by Joëlle Wiels Breakdown of academic impact, for papers by Hans-Georg Rammensee Breakdown of academic impact, for papers by Loredana Saveanu Breakdown of academic impact, for papers by Rachel M. Gerstein Breakdown of academic impact, for papers by Robert Jan Lebbink Breakdown of academic impact, for papers by Brian Zarnegar Breakdown of academic impact, for papers by Berit Jungnickel Breakdown of academic impact, for papers by Marlieke L.M. Jongsma
Rankless by CCL
2026